Systemic treatment options for non-small cell lung cancer after failure of previous immune checkpoint inhibitors: a bayesian network meta-analysis based on randomized controlled trials.

Compared with Chemo, ICI + Antiangio-Ab, TKI + Chemo and SOC all improved ORR, but the difference did not reach statistical significance, while neither ICI + Chemo nor ICI + TKI could improve ORR (Fig. 3 B).

also in 111,027 other papers